MONDAY, March 24, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has approved a new drug for a serious heart condition that affects thousands of people. The drug, called Amvuttra (vutrisiran), is made by Alnylam Pharmaceuticals and is used to treat transthyretin amyloid cardiomyopathy (ATTR-CM). ATTR-CM isContinue Reading
THURSDAY, March 13, 2025 (HealthDay News) — A growing measles outbreak has led to 222 reported cases across Texas, New Mexico and Oklahoma in 2025, with health officials urging more people to get vaccinated. During an interview with Fox News, U.S. Health and Human Services (HHS) Secretary Robert F. KennedyContinue Reading
TUESDAY, March 11, 2025 (HealthDay News) — The National Institutes of Health (NIH) is cutting or canceling more than 40 grants focused on vaccine hesitancy and ways to increase vaccine acceptance, according to an email obtained by The Washington Post. The message — sent Monday by Michelle Bulls, director ofContinue Reading
MONDAY, March 10, 2025 (HealthDay News) — The U.S. Centers for Disease Control and Prevention (CDC) is preparing to study whether vaccines are linked to autism — despite overwhelming scientific evidence showing no connection. The study request came from Trump administration officials, according to sources familiar with the plan. BothContinue Reading
-690x550.jpg)
The five-second intravenous bolus offers faster, simpler administration than ActivaseContinue Reading
THURSDAY, March 6, 2025 (HealthDay News) — Florida’s insurance regulator is demanding detailed prescription data on millions of patients, raising alarms over patient privacy. In January, the Florida Office of Insurance Regulation asked pharmacy benefit managers — companies that manage prescription drug plans — to hand over highly personal dataContinue Reading
THURSDAY, March 6, 2025 (HealthDay News) — The antiviral drug Paxlovid may not offer much protection against COVID-related hospitalizations or deaths for vaccinated older adults after all. Research published recently in JAMA Network Open looked at data from more than 1.6 million adults ages 65 to 74 in Ontario, Canada,Continue Reading
Odactra is an immunotherapy for treatment of house dust mite-induced allergic rhinitisContinue Reading
WEDNESDAY, March 5, 2025 (HealthDay News) — Over-the-counter drugs like aspirin or ibuprofen might help protect against dementia, a new study suggests. These NSAIDs (non-steroidal anti-inflammatory drugs) might help protect the brain by quelling inflammation that contributes to dementia, researchers reported in the Journal of the American Geriatrics Society. PeopleContinue Reading
TUESDAY, March 4, 2025 (HealthDay News) — Many Americans remain unaware of the cancer risk for both men and women posed by human papillomavirus (HPV), a new Ohio State University poll has found. Most people don’t know much about HPV and its long-term cancer risks, and also have key misperceptionsContinue Reading
THURSDAY, Feb. 27, 2025 (HealthDay News) — A federal vaccine advisory panel work session focused on next year’s flu shot has been canceled without explanation. It is the second vaccine advisory meeting that has been canceled or postponed since Robert F. Kennedy Jr., a longtime vaccine skeptic, was confirmed asContinue Reading
President of the American College of Physicians calls for prompt rescheduling of the meetingContinue Reading
TUESDAY, Feb. 25, 2025 (HealthDay news) — Antidepressants are frequently prescribed to people with dementia for symptoms like anxiety, depression, aggressiveness and sleeplessness. But a specific class of antidepressant medications — selective serotonin reuptake inhibitors (SSRIs) — actually might speed up brain decline among some dementia patients, a new SwedishContinue Reading
TUESDAY, Feb. 25, 2025 (HealthDay News) — More emergency room doctors in California are prescribing the anti-addiction medication buprenorphine, contributing to the state’s battle against the U.S. opioid epidemic, a new study suggests. About 16% of scrips written for buprenorphine in California came from an ER doctor in 2022, upContinue Reading